Lu Guo
Impact in
- Hepatology top 10%
- Hepatocellular Carcinoma Treatment and Prognosis
- Hepatitis C virus research
-
- Cancer, Lipids, and Metabolism
Papers in
-
- Hepatocellular Carcinoma Treatment and Prognosis 7
- Surgery 5
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
- Co-authors
- Ke Su (7 shared papers)Hao Zeng (7 shared papers)Tao Gu (5 shared papers)Ke Xu (5 shared papers)Yunwei Han (5 shared papers)Kun He (4 shared papers)Hao Chi (4 shared papers)Han Li (4 shared papers)
- Journals
- Clinical and Experimental Medicine (2 papers)Scientific Reports (1 paper)Biology Direct (1 paper)Journal of Oncology (1 paper)Technology in Cancer Research & Treatment (1 paper)
- Partner nations
- ChinaUnited States
In The Last Decade
Lu Guo
11 papers receiving 151 citations
Peers
Comparison fields: 5 of 38
- Hepatology 71
- Cancer Research 38
- Oncology 40
- Pulmonary and Respiratory Medicine 44
- Epidemiology 46
Countries citing papers authored by Lu Guo
This map shows the geographic impact of Lu Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lu Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lu Guo more than expected).
Fields of papers citing papers by Lu Guo
This network shows the impact of papers produced by Lu Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lu Guo. The network helps show where Lu Guo may publish in the future.
Co-authors
The 25 scholars most cited alongside Lu Guo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 30 | |
| 2 | 2023 | 30 | |
| 3 | 2022 | 30 | |
| 4 | 2023 | 24 | |
| 5 | 2022 | 14 | |
| 6 | 2022 | 8 | |
| 7 | 2024 | 6 | |
| 8 | 2023 | 3 | |
| 9 | 2023 | 3 | |
| 10 | 2023 | 2 | |
| 11 | 2022 | 2 | |
| 12 | 2025 | 0 |
About Lu Guo
Lu Guo is a scholar working on Hepatology, Surgery, Cancer Research, Pathology and Forensic Medicine and Epidemiology, having authored 12 papers that have together received 152 indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (7 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Cancer, Hypoxia, and Metabolism (2 papers), RNA modifications and cancer (2 papers), Cancer Mechanisms and Therapy (2 papers), Ferroptosis and cancer prognosis (2 papers), Cancer-related molecular mechanisms research (2 papers) and Liver Disease Diagnosis and Treatment (2 papers). The work is most often cited by research in Hepatology (71 citations), Cancer Research (38 citations), Oncology (40 citations), Pulmonary and Respiratory Medicine (44 citations) and Epidemiology (46 citations). Lu Guo has collaborated with scholars based in China and United States. Frequent co-authors include Ke Su, Hao Zeng, Tao Gu, Ke Xu, Yunwei Han, Kun He, Hao Chi, Han Li, Yi Jiang and Jiali Chen. Their work appears in journals such as Clinical and Experimental Medicine, Scientific Reports, Biology Direct, Journal of Oncology and Technology in Cancer Research & Treatment.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.